Article
Dual Specificity Phosphatase 6 (DUSP6) Polymorphism Predicts Prognosis of Inoperable Non-Small Cell Lung Cancer after Chemoradiotherapy.
Clinical laboratory - 1 Jan 2016
Wang Tian-Lu, Song Ying-Qiu, Ren Yang-Wu, Zhou Bao-Sen, Wang He-Tong, Bai Lu, Zhang Hai-Bo, Yu Hong, Zhao Yu-Xia
Abstract excerpt
BACKGROUND: Dual-specificity phosphatase 6 (DUSP6) inactivates different target kinases to regulate cell proliferation and differentiation. Altered DUSP6 expressions or gene polymorphisms are associated with human cancer development including non-small cell lung cancer (NSCLC). DNA topoisomerase II alpha (TOP2A) regulates chromosome condensation and chromatid separation, and altered TOP2A expressions are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
